RecruitingNCT06559371

68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer


Sponsor

Kunwei Shen

Enrollment

150 participants

Start Date

Aug 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn whether 68Ga-FAPI PET/CT may be used as a new effective methods for evaluating axillary lymph node efficacy after neoadjuvant treatment for breast cancer. The main question it aims to answer is: Could 68Ga-FAPI PET/CT effectively evaluate axillary lymph node after neoadjuvant treatment for breast cancer? Participants will have a 68Ga-FAPI PET/CT test between last neoadjuvant therapy and surgery.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses a special imaging scan called a FAPI PET/CT to check whether lymph nodes under the arm still contain cancer cells after chemotherapy treatment for breast cancer — helping doctors decide whether those nodes need to be removed during surgery. **You may be eligible if...** - You are a woman aged 18 or older - You have been diagnosed with breast cancer that has spread to lymph nodes under the arm - You have completed at least 3 rounds of chemotherapy (neoadjuvant therapy) before planned surgery - Your general health is good enough to function day-to-day **You may NOT be eligible if...** - Your cancer has spread to other parts of the body (distant metastasis) - You are unable to complete the planned chemotherapy - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Shanghai Jiao Tong University School of Medicine, Ruijin Hospital

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06559371


Related Trials